A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose.
| Autor: | Rubinger, M.1 morel.rubinger@cancercare.mb.ca, Lillicrap, D.2, Rivard, G. E.3, Teitel, J.4, Carcao, M.5, Hensman, C.2, Walker, I.6 |
|---|---|
| Zdroj: | Haemophilia. Mar2008, Vol. 14 Issue 2, p281-286. 6p. 1 Diagram, 4 Charts. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|